Triheksifenidil are anticholinergics that have a central effect is stronger than the peripheral, so widely used to treat Parkinson's disease. This compound works by inhibiting the release of endogenous and exogenous acetyl choline. Central effects on the central nervous system will stimulate the low dose and toxic dose mendepresi on. In oral administration triheksifenidil absorbed quite well and did not accumulate in tissues. Excretion mainly with urine in the form of metabolites.
Composition:
Each tablet contains triheksifenidil hydrochloride 2 mg.
Indications:
All types of Parkinson's disease, including post-encephalitis and idiopathic, drug-induced Parkinson's syndrome, for example reserpina and phenothiazines.
Dose:
Day 1-15 mg divided in 2-4 Adult dose: initial 2 mg, or 3 times a day dosage is increased until the desired result was obtained. Extrapyramidal reactions except for "tardive" dyskinesia. Adults: initial 1 mg, if symptoms are not controlled within a few hours so that missing doses improved symptoms. Daily dose of 5-15 mg, a dose 15-20 mg are rarely required
Packaging:
CEC 100
Avg. Registration:
GKL89209037A1
Production:
PT Indofarma TBK
No comments:
Post a Comment